EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Advances in Therapeutic Antibody Discovery and Development Targeting G Protein‐Coupled Receptors

Catherine J Hutchings iD, Serbülent Ünsal, Mathieu Rappas, Matthew Barnes, Maria Waldhoer, Ben Holland, Martin Culka

Pharmacology Research & Perspectives · 2026-02 · 14 (1)

DOI: 10.1002/prp2.70216 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 20.01.2026. Verfasst von Catherine J Hutchings und 6 weiteren Autor:innen. Beteiligte Einrichtung: Independent Consultant, Hertfordshire, UK. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Drug Discovery, Antibodies, Monoclonal, Antibodies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G protein‐coupled receptors (GPCRs) are integral to numerous biological processes and are associated with various diseases across all therapeutic areas. Consequently, GPCRs present substantial potential for antibody‐based therapies. This review offers an overview of the therapeutic GPCR‐antibody target landscape and examines the diversity within current therapeutic programs at different stages of the research and development pipeline. The progression of the GPCR‐antibody pipeline demonstrates ongoing maturation, reflecting advancements that have addressed several longstanding technical challenges. Additionally, we discuss the rapid expansion of artificial intelligence and machine learning platforms designed to accelerate antibody discovery and clinical development, providing specific examples of their application to GPCRs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledDrug DiscoveryAntibodies, MonoclonalAntibodiesHumansAnimalsMachine LearningArtificial Intelligence

Substanzen

Receptors, G-Protein-CoupledAntibodies, MonoclonalAntibodies

Autor:innen und Institutionen

  • Independent Consultant, Hertfordshire, UK.
  • Antiverse, sbarc|spark, Cardiff, UK.
  • Nxera Pharma UK Ltd, Cambridge, UK.
  • Ikherma Consulting Ltd, Hitchin, Hertfordshire, UK.

ORCID-Profile: Catherine J Hutchings

Zitieren

APA

Hutchings, C. J., Ünsal, S., Rappas, M., Barnes, M., Waldhoer, M., Holland, B., & Culka, M. (2026). Advances in Therapeutic Antibody Discovery and Development Targeting G Protein‐Coupled Receptors. Pharmacology Research & Perspectives, 14(1). https://doi.org/10.1002/prp2.70216

Vancouver

Hutchings CJ, Ünsal S, Rappas M, Barnes M, Waldhoer M, Holland B, et al. Advances in Therapeutic Antibody Discovery and Development Targeting G Protein‐Coupled Receptors. Pharmacology Research & Perspectives. 2026;14(1). doi:10.1002/prp2.70216

BibTeX
@article{Hutchings2026,
  author = {Hutchings, Catherine J and Ünsal, Serbülent and Rappas, Mathieu and Barnes, Matthew and Waldhoer, Maria and Holland, Ben and Culka, Martin},
  title = {Advances in Therapeutic Antibody Discovery and Development Targeting G Protein‐Coupled Receptors},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  volume = {14},
  number = {1},
  doi = {10.1002/prp2.70216}
}
Kostenlos starten →